Lavelle v. Owens-Corning Fiberglas Corp.

507 N.E.2d 476, 30 Ohio Misc. 2d 11, 30 Ohio B. 223, 1987 Ohio Misc. LEXIS 140
CourtCuyahoga County Common Pleas Court
DecidedJanuary 12, 1987
DocketNo. 066351
StatusPublished
Cited by39 cases

This text of 507 N.E.2d 476 (Lavelle v. Owens-Corning Fiberglas Corp.) is published on Counsel Stack Legal Research, covering Cuyahoga County Common Pleas Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lavelle v. Owens-Corning Fiberglas Corp., 507 N.E.2d 476, 30 Ohio Misc. 2d 11, 30 Ohio B. 223, 1987 Ohio Misc. LEXIS 140 (Ohio Super. Ct. 1987).

Opinion

James J. McMonagle, J.

The narrow issue presented in this asbestos exposure, products liability case arises from the defendants’ request for an in limine order prohibiting the asbestosis-afflicted plaintiff from adducing at trial any evidence regarding .cancer, any causal relationship between asbestos and cancer, or any increased risk or fear of developing cancer.

Nowhere is the symbiotic relationship between law and medicine more evident than in asbestos litigation generally and the particular issue raised herein. The insidious, progressive nature of asbestos-related diseases as discovered by the medical community forced the legal community to re-think its traditional approach as to when the statute of limitations commences. The lengthy gestation period of these diseases, as revealed in the medical literature, now brings into question the long-standing legal theories that have held that there can be only one recovery for all injuries — past, present and future. In order to insure scientific validity, medical research deals with groups, cohort studies, statistics and mathematics. Lawsuits, however, deal with an individual claimant, his or her specific medical condition and his or her own medical future. This [12]*12conflict in methodologies also complicates the law-medicine braid.

The inhalation of asbestos fibers causes many diseases, the most common being asbestosis,1 which is generally referred to as a scarring of the lung.2 Asbestos exposure can also produce other non-cancerous diseases in both the pleural (chest) cavity and the peritoneal (stomach) cavity. Most common of these are pleural plaques (hard white collagenous lesions on the lung or diaphragm), pleural fibrosis (a thickening of the outer membrane covering the lung), pleural effusions (inflammation on the lung), and pleural pseudotumors (lesions or masses appearing on a radiograph or CAT scan of the chest but disappearing upon surgery).

With the exception of malignant mesothelioma (a diffuse tumor arising from the mesothelial cells, i.e., those cells on the surface lining of pleura, peritoneum and pericardium),3 the causal relationship between asbestos exposure and other types of cancers, especially lung cancer, is not as clear. Even though early medical studies linked asbestos exposure and lung cancer,4 there is no uniformly accepted medical consensus that the progressive nature of asbestosis always matures into lung cancer.

However, one expert on the subject of occupational carcinogenesis has written:

“Of one million current and former American asbestos workers that still survive, fully 300,000 can be projected to die of cancer. Indeed, 1 in 5 of these men can be expected to develop cancer of the lung; 1 in 10, cancer of the gastrointestinal tract; and another 1 in 20 of pleural mesothelioma, an always fatal tumor of the pleura or peritoneum.” Wagoner, Occupational Carcinogenesis: The Two Hundred Years Since Percival Potts (1976), 27 Annals, N.Y. Acad. Science 1-2.

At least since 1965, when the study by Dr. I. J. Selikoff was published, there have been ongoing scientific inquiries into the effects of prolonged asbestos exposure on the health of workers. The impact on the legal system was not immediately felt. Because there has been recent expansion of strict liability in tort under Section 402A of the Restatement of the Law 2d, Torts (1965), and because the latency period for asbestos-related diseases is twenty years on the average, an astounding number of lawsuits, along with the widespread movement to compensate injured workers, has just surfaced in the last five years.

[13]*13Increased Risk of Cancer

In Greek mythology, Tantalus was a king and a son of Zeus, whose punishment in the lower world was eternal hunger and thirst. He was doomed to stand beneath branches laden with fruit which he could never reach. As with this legendary king, it is tempting and tantalizing for this court to open up the sphere of recovery and the scope of damages in an asbestos case. However, this court must not lose sight of the burden of proof confronting a plaintiff, of the elements of the cause of action which must be satisfied, and of the purpose of compensation as distinguished from punishment.

The plaintiff, who is petitioning the court on this issue, is suffering from the disease of asbestosis, not cancer. Simply stated, to permit recovery for the increased risk of cancer would be to allow speculation:

“Not only must the injury complained of, and for which damages are sought, be the direct, proximate, and probable result of the wrong, and not a remote consequence, but the injury, and the damages resulting, must be shown with certainty, and not be left to speculation or conjecture, whether the action is in contract or tort; damages which are uncertain, speculative, or conjectural cannot be recovered.” 30 Ohio Jurisprudence 3d (1981) 24, Damages, Section 14.

Moreover, evidence that pain, suffering, or a condition “might” or “may” result from the injury complained of is incompetent; the evidence must tend to show that reasonable certainty of such result exists. See Cooper v. Sisters of Charity (1971), 27 Ohio St. 2d 242, 249-252, 56 O.O. 2d 146, 150-151, 272 N.E. 2d 97, 102-104. Plaintiff, through his medical expert, must establish probabilities, not mere possibilities.

Cancer is a separate disease process from asbestosis. Evidence cannot be adduced that asbestosis will inevitably lead to cancer. The only nexus between the pathologies of these two diseases is that they can be caused by the same carcinogen — asbestos fibers.

A plaintiff can never prove causation of a disease which has not yet manifested itself. Exposure to asbestos fibers can cause asbestosis. Exposure to asbestos fibers can result in cancer. Asbestosis does not necessarily develop into cancer. Thus, there is a gap in the logical progression. To hold a defendant manufacturer responsible for the future occurrence of cancer would entail treating the manufacturer as an absolute insurer of its product. This is not only unfair in light of the flawed analysis above, but it is not a desirable philosophy.5 Certainly, there is an interest in promoting the economic health of businesses which generate income and provide jobs.

Section 402A of the Restatement of the Law 2d, Torts, provides that an unavoidably unsafe product may nevertheless be marketed, but the seller or manufacturer is responsible for informing consumers or users of the risk of harm. Thus, manufacturers have been held to the knowledge and skill of an expert in products liability cases. Consequently, they must keep informed of scientific breakthroughs concerning their products. A manufacturer’s duty to warn extends to the ultimate user, and any warnings must be designed to reach that user. It is the plaintiffs contention here that the scope of the manufacturers’ duty to warn is dependent upon the range of possible adverse health effects posed by exposure to harmful products. It follows, then, that evidence of increased risk of cancer should be admissible to define the parameters of the defendants manufacturers’ obligations to adequately test and to adequately warn. This is not a [14]*14persuasive argument. Every case should turn upon a duty as it relates to the individual plaintiffs position, i.e., the individual plaintiffs injuries.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Finley v. First Realty Property Management, Ltd.
924 N.E.2d 378 (Ohio Court of Appeals, 2009)
Slane v. Metamateria Partners, L.L.C.
892 N.E.2d 498 (Ohio Court of Appeals, 2008)
Lloyd v. General Motors Corp.
916 A.2d 257 (Court of Appeals of Maryland, 2007)
Norfolk & Western Railway Co. v. Ayers
538 U.S. 135 (Supreme Court, 2003)
Bouchard v. American Home Products Corp.
213 F. Supp. 2d 802 (N.D. Ohio, 2002)
McCafferty v. Centerior Service Co.
983 F. Supp. 715 (N.D. Ohio, 1997)
Metro-North Commuter Railroad v. Buckley
521 U.S. 424 (Supreme Court, 1997)
Boryla v. Pash
937 P.2d 813 (Colorado Court of Appeals, 1997)
Williams v. Warren General Hospital
684 N.E.2d 730 (Ohio Court of Appeals, 1996)
Simmons v. Pacor, Inc.
674 A.2d 232 (Supreme Court of Pennsylvania, 1996)
Michael Buckley v. Metro-North Commuter Railroad
79 F.3d 1337 (Second Circuit, 1996)
Russell v. Steck
851 F. Supp. 859 (N.D. Ohio, 1994)
Day v. NLO
851 F. Supp. 869 (S.D. Ohio, 1994)
Potter v. Firestone Tire & Rubber Co.
863 P.2d 795 (California Supreme Court, 1993)
Cantrell v. Gaf Corporation
999 F.2d 1007 (Sixth Circuit, 1993)
Cantrell v. GAF Corp.
999 F.2d 1007 (Sixth Circuit, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
507 N.E.2d 476, 30 Ohio Misc. 2d 11, 30 Ohio B. 223, 1987 Ohio Misc. LEXIS 140, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lavelle-v-owens-corning-fiberglas-corp-ohctcomplcuyaho-1987.